Scientists studying the health benefits of CBD have found it is a promising natural Since CBD (cannabidiol) and other compounds in cannabis are so similar to the . 9. Depression and Mood Disorders. Clinical depression is a serious mood . Other cannabinoids are also shown to relieve pain, including CBC, CBG. Whole or crude marijuana (including marijuana oil or hemp oil) is not approved Different compounds in marijuana have different actions in the human body. For example, deltatetrahydrocannabinol (THC) seems to cause the Nabiximols has shown promise for helping people with cancer pain that's. Here are seven health benefits of CBD oil that are backed by scientific evidence. of THC and CBD, is approved in several countries to treat pain related to disability worldwide, while anxiety disorders are ranked sixth (9).
CBD Different Have 9.) for Pain and THC Benefits
While its legal here to use medical cannabis, the lack of knowledge by doctors here including a Dutch doctor, make it difficult to consult on the interaction and the possibility of what we desire, which is to cut down on his Xarelto and Pletal, even if its just incremental, i.
This is our hope, but we are on our own as far as knowledge of the two sides i. It will be we who decide IF to wean, which drug to wean off, or a bit of both, or all of one.. So finally to my question Whats the question? If his blood work comes back that all is ok re blood texture clotting etc, then weaning off is bad? Why the muscle loss?
He has also experienced some dizziness light headed this last year which again, timing wise, ties into the addition of FECO to his diet but Im not blaming the FECO, Im hoping the FECO is acting as a blood thinner and that we can reduce the Chem meds which according to studies Ive read with tears streaming down my face, have multiple side effects.
Since the incident in Ive suffered from PTSD and my sincerest wish is to if not have closure on this, to after 5 years, adjust his medication and see some sort of forward progress in that area.
The idea of him taking this the rest of his life when it may be unnecessary is horrific. We do not have access to a medical doctor who is also familiar with cannabis, so Peter I ask of you with your background and your education and family history with your grandfather, do you feel we are on the right track? My husband seems healthy but his muscle loss over the last 7 months is dramatically visible and it frightens me him too quietly but he doesnt say much and he is tired a lot but at the same time very active.
This is an ex rugby player, full of energy who moves and is busy all day. He should not be losing muscle mass. No one can answer our questions or even nudge us in the right direction.
A nudge from you would be very much appreciated. When have we crossed a line? He needs that muscle mass to take him through the rest of his life, his muscle mass at the time of the incident in is what saved his life without doubt.. Should the same thing happen today I know I would lose him. Any thought please xx.
Hi Neva, Thank you for your comment. You situation is really complicated! I would definitely consult with a Hematologist, ideally one who is comfortable with cannabis therapeutics, so they can see this issue from all sides. This might be hard to find but hopefully you can connect with one. What about Cardiovascular effects of Marijuana?
There so many different opinions and contradictions in research online i dont even know what to listen to. And because its so politically polarized with politicians and special interest Big Pharma? For example, some studies may imply cannabis causes some or other ill consequence but, if you actually read the study carefully, the cannabis and the ill consequence are just randomly associated, and have no causal relationship to each other whatsoever, and may even be caused by the same root causes.
Thanks for your reply. I agree and there needs to be a lot more non byas research especially for medical marijuana patients that are concerned about there heart and health. It would be nice to know the real effects and what we are dealing with. Thank you very much for sharing this great article about Medical Cannabis.
You are most welcome to take a look at this article, about the same topic: Thank you for this blog. It is interesting as well as informative. Does one go to the pharmacy to pick up your med? Once certified by a physician, patients typically go to a dispensary to pick up their medical cannabis.
As a Canadian I am pleased to report the legality of using cannabis is confidently striding into the near future.
There is some interesting evidence along these lines, for example: I really appreciate this piece. As a SICI fellow my focus is on solving the problem of misinformation and missing information and chaos of regulating a highly politicized controlled substance. There are huge gaps in our knowledge and credible analysis of the information that is available. Do you have any suggestions of who I should reach out to?
My email is kht student. I can help but not via mechanism of response to comments on blog; please reach out to me via my website petergrinspoon. Hello Peter, I am currently writing a research paper on the benefits of medical marijuana and was wondering if you could provide me with a few reliable sources, or maybe a list of benefits?
Hi Roberto, this is a good resource: Is it true that marijuana can actually help to loss weight? I have been reading this marijuana strain here in and all it says that it can help you relax and chill you physically and mentally. Some of them might even help you with depression and anxiety but this issue regarding losing weight when using marijuana is just fascinating. Can you enlighten me with some new information about this?
There is some research along those lines. This article sums it up. Hi Daniele, Just to offer my experience. I started taking Full Extract Cannabis Oil 9 months ago this has THC but the psychoactive effects can be avoided by weaning on very slowly, very very very slowly with tiny tiny micro doses I hate the psychoactive effects. I am 58 and have been obese for about 10 years. Slowly gently but relentlessly downwards. I still today cant believe it because i had genuinely given up, 58 years old and very fat with sore knees and nothing I did diligently might I add changed a thing, in fact everything I tried resulted in an increased weight after the fact.
Cannabis has made me lose a huge amount of weight and I am still consistently gently heading downwards. Please note, I researched strains and studied for months and months before taking the oil, I grew my own plants and made my own Full Extract Oil with a clean solvent ethanol using the Rick Simpson method which is safest for home makers, except for his solvents which are not clean, so I used his method with rice cooker but I used my own choice of a clean solvent which is ethanol food grade.
If you are contemplating taking this oil you need to self educate, you need to understand that the oil has THC in it and you need to wean on super slowly to use it without the horrible psychoactive feelings that the THC bring if you have not weaned on slowly, and you need to be patient once you start. Might I suggest that you start with a tincture as I did until I was no longer scared of it, tincture is not as strong and is a good prelude to starting on the oil.
You need to grow your own so you know what you are taking.. You need to control what you are taking from beginning to end. I suggest an Indica, not Sativa as the Sativas can have an anxiety effect, well it did with me while the Indica strains are more relaxing, but the dose needs to start and remain tiny, you are not trying to treat cancer, you are not increasing your dose, you are just feeding your endocannabinoid receptors with a steady micro dose 3 times a day and your body will do the rest.
Jorge Cervantes wrote a Medical Cannabis book that will assist in you growing your own indoors or out, everything from beginning to end. About 4 plants should do it, find a safe place to grow them indoors under light or outdoors if you have a secluded spot. Cervantes also gives recipes for tincture and other edibles, but eventually you should progress to the oil using the rice cooker method EXACTLY as Rick Simpson says but with a clean solvent. My doc is unaware of my cannabis taken orally but very impressed with my weight loss which he thinks is down to diet and exercise.
PS Smoking does not achieve anything, we are talking tincture or full extract oil taken orally xx. The US government is adamant that there are none. If you, Harvard, are saying that there are benefits, how is it legal to keep the classification the same?
What is going on here? It needs to change. Also, this may be a question that you may not be able to, or want to answer, but, does the classification have anything to do with giving up the monopoly in regards to research? Is it about the money? Something is very wrong here. A complete comprehensive article I will say.
Looking at the benefits it can offer, it should be legalised. Thanks for the share. I am 46 and have suffered from migraines for nearly 25 years. They have become less frequent a few per month instead of a few per week , but harder to control with rescue medications such as relpax.
At the same time, educated and aware patients can be their own highly informed health consultants. For anxiety, CBD products with a ratio of High-CBD cannabinoids can be very effective in reducing chronic anxiety, treating temporary stress, and protecting the body from the physiological effects of both.
Varieties high in linalool, a terpene shared with lavender, are known to be effective for relieving anxiety. Always start with the micro dose to test sensitivity and go up as needed within the dosing range, before going to the next, until symptoms subside. The micro to standard dose is usually recommended to treat stress and anxiety with CBD.
For relief of immediate symptoms, as in a panic or anxiety attack, vaporizing or smoking work well. The medication lasts one to three hours, whereas most ingested products, including CBD oil, take thirty to sixty minutes before taking effect and last six to eight hours. Herbal vaporizers that use the whole plant are also an effective delivery method. Sublingual sprays or tinctures taken as liquid drops take effect quickly and last longer than inhaled products.
The Cannabis Health Index CHI is an evidence-based scoring system for cannabis in general, not just CBD oil effects and its effectiveness on various health issues based on currently available research data. Using this rubric and based on eleven studies, cannabis rated in the possible-to-probable range of efficacy for treatment of anxiety.
Elixinol Organic High Potency CBD Capsules Elixinol offers a highly concentrated, high-potency, organic whole-hemp plant CBD oil , which is naturally extracted with carbon dioxide and free of all synthetics and chemicals. Whole-hemp plant extracts contain synergistic compounds that are believed to enhance the effectiveness and benefits of CBD.
Clinical depression is a serious mood disorder characterized by persistent sadness and loss of interest, sometimes leading to decreased appetite and energy and suicidal thoughts. Commonly used pharmaceuticals for depression often target serotonin, a chemical messenger that is believed to act as a mood stabilizer. The neural network of the endocannabinoid system works similarly to the way that serotonin, dopamine, and other systems do, and, according to some research, cannabinoids have an effect on serotonin levels.
Whereas a low dose of THC increases serotonin, high doses cause a decrease that could worsen the condition. CBD products with a ratio of Specifically, products made with Valentine X or Electra 4 are more energizing, helping relieve depression. When low energy is an issue, sativa or other stimulating strains can be helpful for improving energy and focus when THC can be tolerated. Varieties that are high in the terpene limonene are recommended for mood elevation.
Always start with the micro dose to test sensitivity and go up as needed within the dosing range before going to the next, until symptoms subside. The micro to standard dose is usually recommended to treat depression. Vaporized or smoked cannabis is recommended for relief of immediate symptoms, or a boost in dosage, and it can also be useful for sleep issues.
The Cannabis Health Index CHI is an evidence-based scoring system for cannabis in general, not just CBD effects and its effectiveness on various health issues based on currently available research data. Using this rubric and based on twenty-one studies, cannabis rated in the possible-to-probable range of efficacy for treatment of depression.
Research in called for clinical trials to look into the effectiveness of cannabinoids for bipolar disorder manic depression. It also works on the GABA-glutamate system and the hypothalamic-pituitary-adrenal axis. Its main role is restoring balance through inhibition when levels are too high and enhancement when they are too low. This is the most likely reason phytocannabinoids in general and CBD specifically are able to regulate depression and anxiety.
The scientific inquiry into cannabis over the past several decades has confirmed that it is an effective and safe analgesic for many kinds of pain.
Of all the reasons that people use CBD today, pain is the most common. The same can be said of cannabis in general. In the United States, over seventy million people suffer from chronic pain, which is defined as experiencing over one hundred days per year of pain. Physicians differentiate between neuropathic usually chronic and nociceptive pains usually time-limited , and cannabis works on most neuropathic and many nociceptive types of pain.
A number of studies have demonstrated that the endocannabinoid system is both centrally and peripherally involved in the processing of pain signals. Cannabinoids can be used along with opioid medications, and a number of studies have demonstrated that they can reduce the amount of opioids needed, lessen the buildup of tolerance, and reduce the severity of withdrawal. It is suggested that patients work with a health care practitioner experienced in recommending CBD oil or medicinal cannabis so that dosage and delivery methods can be developed and fine-tuned on an individual basis.
Oral CBD products with a ratio of Most discussions of treating pain with CBD suggest that finding the right dosage is critical. Always start with the micro dose to test sensitivity and go up as needed within the dosing range by body weight until symptoms subside. If CBD-dominant products alone are not enough to treat a particular case, products with a higher ratio of THC are sometimes recommended to better manage pain.
For day use, more stimulating, sativa varieties with higher concentrations of myrcene could be added to the formula. In general, for pain, and especially for evening and nighttime, indica strains are favored for their relaxing, sedative effect. A person without experience with THC should use caution and titrate slowly up to higher doses.
Research as well as patient feedback have indicated that, in general, a ratio of 4: THC is the most effective for both neuropathic and inflammatory pain. Each individual is different, however—for some, a 1: Chemotypes high in beta-caryophyllene, myrcene, and linalool provide additional pain relief and increase the effectiveness of other cannabinoids for analgesia. For relief of immediate symptoms, as in a flare-up of pain, vaporizing or smoking work well.
The medication effect is immediate and lasts one to three hours, whereas most ingested products take thirty to sixty minutes before taking effect faster on an empty stomach and last six to eight hours. Sublingual sprays or tinctures taken as liquid drops also take effect quickly and last longer than inhaled products.
When pain is localized, topical products can be applied. Topicals affect the cells near application and through several layers of tissue but do not cross the blood-brain barrier and are, therefore, not psychoactive. Amotivational syndrome in organic solvent abusers.
Characteristics of abnormal behavior induced by delta 9-tetrahydrocannabinol in rats. Psychiatric aspects of cannabis use in adolescents and young adults. Related, induced and associated psychiatric disorders to cannabis. Operant acquisition of marihuana in man. Cannabis, motivation, and life satisfaction in an internet sample. Subst Abuse Treat Prev Policy.
Endocannabinoids in the regulation of appetite and body weight. Endocannabinoids in appetite control and the treatment of obesity. Genetic variations at the endocannabinoid type 1 receptor gene CNR1 are associated with obesity phenotypes in men.
J Clin Endocrinol Metab. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. The role of CB1 receptors in sweet versus fat reinforcement: SR , a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: Clinical trials update and cumulative meta-analyses from the American College of Cardiology: Eur J Heart Fail.
Rimonabant improves cardiometabolic risk profile in obese or overweight subjects: Rimonabant in obese patients with type 2 diabetes. Am J Health Syst Pharm.
Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manage. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.
Dronabinol effects on weight in patients with HIV infection. The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. Cannabinoids in the treatment of the cachexiaanorexia syndrome in palliative care patients. A phase II study of deltatetrahydrocannabinol for appetite stimulation in cancer-associated anorexia.
Mechanism of action of cannabinoids: An efficient new cannabinoid antiemetic in pediatric oncology. Cannabinoids for control of chemotherapy induced nausea and vomiting: Therapeutic potential of cannabinoids in trigeminal neuralgia. Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients. Int J Clin Pharmacol Res.
Are oral cannabinoids safe and effective in refractory neuropathic pain? Lack of analgesic efficacy of oral deItatetrahydrocannabinol in postoperative pain. Pain relief with oral cannabinoids in familial Mediterranean fever. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis - secondary publication.
The analgesic properties of deItatetrahydrocannabinol and codeine. Analgesic effect of deItatetrahydrocannabinol. Cannabis use for chronic non-cancer pain: Cannabis use in HIV for pain and other medical symptoms. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain: Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: Cannabimimetic properties of ajulemic acid.
A tale of two cannabinoids: Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin. Initial experiences with medicinal extracts of cannabis for chronic pain: Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Combined cannabinoid therapy via an oromucosal spray. Cannabinoids for the treatment of pain: An update on recent clinical trials.
Dexanabinol HU effect on experimental autoimmune encephalomyelitis: Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice.
Marihuana as a therapeutic agent for muscle spasm or spasticity. Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors. DeltaTHC in the treatment of spasticity associated with multiple sclerosis. Adv Alcohol Subst Abuse. Nabilone in the treatment of multiple sclerosis.
Effect of cannabinoids on spasticity and ataxia in multiple sclerosis. Treatment of human spasticity with deltatetrahydrocannabinol. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: Int J Clin Pharmacol Ther.
Tremor in multiple sclerosis. Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Tetrahydrocannabinol for tremor in multiple sclerosis. The effect of cannabis on tremor in patients with multiple sclerosis. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis. The effect of cannabis on urge incontinence in patients with multiple sclerosis: Curr Opin Investig Drugs.
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis?
A double-blind, randomized, placebo-controlled study on patients. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis CAMS study: Cannabinoids in multiple sclerosis CAMS study: J Neurol Neurosurg Psychiatry. From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches. Cannabinoids in MS - are we any closer to knowing how best to use them?
The endocannabinoid pathway in Huntington's disease: Cannabinoid system and neuroinflammation: Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Neuroprotective cannabinoid receptor antagonist SRA prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Dexanabinol HU in the treatment of severe closed head injury: Efficacy and safety of dexanabinol in severe traumatic brain injury: Cannabinoid-based drugs as anti-inflammatory therapeutics.
Anti-inflammatory property of the cannabinoid agonist WIN in a rodent model of chronic brain inflammation. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Involvement of the cannabimimetic compound, N-palmitoyl-ethanoIamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies.
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats.
CB1 cannabinoid receptor signalling in Parkinson's disease. The cannabinoid receptor agonist WIN 55, reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease. Effects of levodopa on endocannabinoid levels in rat basal ganglia: Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: DeIta9-tetrahydrocannabinol improves motor control in a patient with musician's dystonia. Cannabis for dyskinesia in Parkinson disease: Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia.
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease. Survey on cannabis use in Parkinson's disease: AIsasua del Valle A.
Implication of cannabinoids in neurological diseases. An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments. Potential role of cannabinoids in Parkinson's disease. The pattern of neurodegeneration in Huntington's disease: Selective vulnerability in Huntington's disease: Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
The cannabinoid receptor agonist WIN 55, attenuates the effects induced by quinolinic acid in the rat striatum. Controlled clinical trial of cannabidiol in Huntington's disease.
Cannabinoids reduce symptoms of Tourette's syndrome. Delta 9-tetrahydrocannabinol THC is effective in the treatment of tics in Tourette syndrome: Tourette syndrome is not caused by mutations in the central cannabinoid receptor CNR1 gene. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.
AM , a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. The CB2 cannabinoid agonist AM prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. Survey of cannabis use in patients with amyotrophic lateral sclerosis. A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease. Int J Geriatr Psychiatry.
DeItatetrahydrocannabinol for nighttime agitation in severe dementia. Anticonvulsant activity of four oxygenated cannabidiol derivatives. Res Commun Chem Pathol Pharmacol. Antiepileptic potential of cannabidiol analogs. Structure-anticonvulsant activity relationships of cannabidiol analogs.
Anticonvulsant effect of cannabidiol. S Afr Med J. Cannabidiol-antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
Anticonvulsant interaction of cannabidiol and ethosuximide in rats. Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy. Cannabinoid CB1 receptor antagonists cause status epilepticus-Iike activity in the hippocampal neuronal culture model of acquired epilepsy. Arachidonyl-2'-chIoroethyIamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Grand mal convulsions subsequent to marijuana use.
Cannabinoids in health and disease
Get the facts on CBD oil, a natural product that may ease your anxiety and It's also said that CBD oil can promote sounder sleep, reduce inflammation and pain, fight at findings from recent studies on several other possible benefits of CBD oil: For the study, nine healthy male volunteers took a single dose of either CBD. It was, however, not until that ∆9-tetrahydrocannabinol (∆9-THC), the There are some negative effects of cannabis use other than addiction, most of . Cannabis has been used for millennia as a pain-relieving substance. an overall benefit of THC in pain and quality of life in patients with refractory neuropathic pain. Full Spectrum CBD Oil is commonly used for assisting with pain, stress, Several studies have shown that Omega 3 supplementation can.